For example, high FABP3 expression promotes gastric carcinoma aggressiveness and poor survival rate, FABP7 is a marker for renal cell carcinomas 20, FABP5 is associated with drug‐resistant in pancreatic cancer and had a significant role for FABP5 in HCC progression and metastasis through the induction of epithelial‐to‐mesenchymal transition 21. Here, FABP3 is linked to hepatocellular carcinoma.